PLPPR2
Phospholipid phosphatase-related protein type 2
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
biological process | 0 | ||
biological term | 0 | ||
cell line | 0 | ||
cell type or tissue | 0 | ||
cellular component | 0 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Class A/1 (Rhodopsin-like receptors) | ||||
Reactome | GPCR ligand binding | ||||
Reactome | Lysosphingolipid and LPA receptors | ||||
Reactome | Signal Transduction | ||||
Reactome | Signaling by GPCR | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Class A/1 (Rhodopsin-like receptors) | ||||
GPCR ligand binding | ||||
Lysosphingolipid and LPA receptors | ||||
Signal Transduction | ||||
Signaling by GPCR | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Inferred from Biological aspect of Ancestor (IBA) | GO_Central | |||
Inferred from Biological aspect of Ancestor (IBA) | GO_Central | |||
Inferred from Biological aspect of Ancestor (IBA) | GO_Central | |||
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
total cholesterol measurement | 2 | 2 | 2 | 80.2 | |||||
diastolic blood pressure | 1 | 1 | 1 | 78.6 | |||||
Agents acting on the renin-angiotensin system use measurement | 1 | 1 | 1 | 76.5 | |||||
3 | 1 | 1 | 7.8 | 65.4 | |||||
Calcium channel blocker use measurement | 1 | 1 | 1 | 64.9 | |||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
total cholesterol measurement | 2 | 80.2 | |||||
diastolic blood pressure | 1 | 78.6 | |||||
Agents acting on the renin-angiotensin system use measurement | 1 | 76.5 | |||||
1 | 7.8 | 65.4 | |||||
Calcium channel blocker use measurement | 1 | 64.9 | |||||
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Macaque | phospholipid phosphatase related 2 | 714388 | ||||||
Mouse | MGI:2384575 | 235044 | ||||||
Rat | RGD:1597171 | 300443 | ||||||
Dog | phospholipid phosphatase related 2 | 484944 | ||||||
Horse | phospholipid phosphatase related 2 | 100057105 | ||||||
Species | Name | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|
Macaque | phospholipid phosphatase related 2 | |||||
Mouse | ||||||
Rat | ||||||
Dog | phospholipid phosphatase related 2 | |||||
Horse | phospholipid phosphatase related 2 | |||||
PMID | Year | Title |
---|